▶ 調査レポート

拡張型心筋症薬品の世界市場2017

• 英文タイトル:Global Dilated Cardiomyopathy Therapeutics Market Size, Status and Forecast 2022

QYResearchが調査・発行した産業分析レポートです。拡張型心筋症薬品の世界市場2017 / Global Dilated Cardiomyopathy Therapeutics Market Size, Status and Forecast 2022 / A04108238資料のイメージです。• レポートコード:A04108238
• 出版社/出版日:QYResearch / 2017年3月7日
• レポート形態:英文、PDF、104ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:産業未分類
• 販売価格(消費税別)
  Single User¥349,800 (USD3,300)▷ お問い合わせ
  Enterprise¥699,600 (USD6,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、拡張型心筋症薬品の世界市場について調査・分析し、拡張型心筋症薬品のメーカー別販売量、市場シェア分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、拡張型心筋症薬品産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。(※Sales:拡張型心筋症薬品の販売量、Revenue:拡張型心筋症薬品の売上高)

・拡張型心筋症薬品市場概要
・拡張型心筋症薬品のメーカー別販売量・メーカー別シェア
・拡張型心筋症薬品の世界市場:用途別販売量・市場シェア
・拡張型心筋症薬品の世界市場:地域別販売量・市場シェア
・拡張型心筋症薬品のアメリカ市場規模
・拡張型心筋症薬品の中国市場規模
・拡張型心筋症薬品のヨーロッパ市場規模
・拡張型心筋症薬品の日本市場規模
・拡張型心筋症薬品の東南アジア市場規模
・拡張型心筋症薬品のインド市場規模
・拡張型心筋症薬品のメーカー別分析(企業概要、事業概要、商品概要、収益、価格等)
・拡張型心筋症薬品のコスト分析・価格動向
・拡張型心筋症薬品の産業チェーン(サプライチェーン分析)
・拡張型心筋症薬品のマーケティング戦略・販売チャネル、流通業者
・拡張型心筋症薬品市場への影響要因分析
・拡張型心筋症薬品の世界市場予測
・拡張型心筋症薬品のアメリカ市場予測
・拡張型心筋症薬品の中国市場予測
・拡張型心筋症薬品のヨーロッパ市場予測
・拡張型心筋症薬品の日本市場予測
・拡張型心筋症薬品の東南アジア市場予測
・拡張型心筋症薬品のインド市場予測
・拡張型心筋症薬品の用途別世界市場予測
...

This report studies the global Dilated Cardiomyopathy Therapeutics market, analyzes and researches the Dilated Cardiomyopathy Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Array BioPharma
AstraZeneca
Celladon Corporation
GlaxoSmithKline
Janssen Pharmaceuticals
Merck & Co
Novartis International
Pfizer
Sanofi
Teva Pharmaceutical Industries
Vericel Corporation
PhaseBio Pharmaceuticals
Johnson and Johnson

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Application, Dilated Cardiomyopathy Therapeutics can be split into
Application 1
Application 2

レポート目次

Table of Contents

Global Dilated Cardiomyopathy Therapeutics Market Size, Status and Forecast 2022
1 Industry Overview of Dilated Cardiomyopathy Therapeutics
1.1 Dilated Cardiomyopathy Therapeutics Market Overview
1.1.1 Dilated Cardiomyopathy Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Dilated Cardiomyopathy Therapeutics Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Dilated Cardiomyopathy Therapeutics Market by End Users/Application
1.3.1 Application 1
1.3.2 Application 2

2 Global Dilated Cardiomyopathy Therapeutics Competition Analysis by Players
2.1 Dilated Cardiomyopathy Therapeutics Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Array BioPharma
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Dilated Cardiomyopathy Therapeutics Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 AstraZeneca
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Dilated Cardiomyopathy Therapeutics Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Celladon Corporation
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Dilated Cardiomyopathy Therapeutics Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 GlaxoSmithKline
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Dilated Cardiomyopathy Therapeutics Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Janssen Pharmaceuticals
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Dilated Cardiomyopathy Therapeutics Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Merck & Co
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Dilated Cardiomyopathy Therapeutics Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Novartis International
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Dilated Cardiomyopathy Therapeutics Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Pfizer
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Dilated Cardiomyopathy Therapeutics Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Sanofi
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Dilated Cardiomyopathy Therapeutics Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Teva Pharmaceutical Industries
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Dilated Cardiomyopathy Therapeutics Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Vericel Corporation
3.12 PhaseBio Pharmaceuticals
3.13 Johnson and Johnson

4 Global Dilated Cardiomyopathy Therapeutics Market Size by Application (2012-2017)
4.1 Global Dilated Cardiomyopathy Therapeutics Market Size by Application (2012-2017)
4.2 Potential Application of Dilated Cardiomyopathy Therapeutics in Future
4.3 Top Consumer/End Users of Dilated Cardiomyopathy Therapeutics

5 United States Dilated Cardiomyopathy Therapeutics Development Status and Outlook
5.1 United States Dilated Cardiomyopathy Therapeutics Market Size (2012-2017)
5.2 United States Dilated Cardiomyopathy Therapeutics Market Size and Market Share by Players (2016 and 2017)

6 EU Dilated Cardiomyopathy Therapeutics Development Status and Outlook
6.1 EU Dilated Cardiomyopathy Therapeutics Market Size (2012-2017)
6.2 EU Dilated Cardiomyopathy Therapeutics Market Size and Market Share by Players (2016 and 2017)

7 Japan Dilated Cardiomyopathy Therapeutics Development Status and Outlook
7.1 Japan Dilated Cardiomyopathy Therapeutics Market Size (2012-2017)
7.2 Japan Dilated Cardiomyopathy Therapeutics Market Size and Market Share by Players (2016 and 2017)

8 China Dilated Cardiomyopathy Therapeutics Development Status and Outlook
8.1 China Dilated Cardiomyopathy Therapeutics Market Size (2012-2017)
8.2 China Dilated Cardiomyopathy Therapeutics Market Size and Market Share by Players (2016 and 2017)

9 India Dilated Cardiomyopathy Therapeutics Development Status and Outlook
9.1 India Dilated Cardiomyopathy Therapeutics Market Size (2012-2017)
9.2 India Dilated Cardiomyopathy Therapeutics Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Dilated Cardiomyopathy Therapeutics Development Status and Outlook
10.1 Southeast Asia Dilated Cardiomyopathy Therapeutics Market Size (2012-2017)
10.2 Southeast Asia Dilated Cardiomyopathy Therapeutics Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions and Application (2017-2022)
11.1 Global Dilated Cardiomyopathy Therapeutics Market Size (Value) by Regions (2017-2022)
11.1.1 United States Dilated Cardiomyopathy Therapeutics Revenue and Growth Rate (2017-2022)
11.1.2 EU Dilated Cardiomyopathy Therapeutics Revenue and Growth Rate (2017-2022)
11.1.3 Japan Dilated Cardiomyopathy Therapeutics Revenue and Growth Rate (2017-2022)
11.1.4 China Dilated Cardiomyopathy Therapeutics Revenue and Growth Rate (2017-2022)
11.1.5 India Dilated Cardiomyopathy Therapeutics Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Dilated Cardiomyopathy Therapeutics Revenue and Growth Rate (2017-2022)
11.2 Global Dilated Cardiomyopathy Therapeutics Market Size (Value) by Application (2017-2022)
11.3 The Market Drivers in Future

12 Dilated Cardiomyopathy Therapeutics Market Dynamics
12.1 Dilated Cardiomyopathy Therapeutics Market Opportunities
12.2 Dilated Cardiomyopathy Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Dilated Cardiomyopathy Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Dilated Cardiomyopathy Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Dilated Cardiomyopathy Therapeutics Product Scope
Figure Global Dilated Cardiomyopathy Therapeutics Market Size (Million USD) (2012-2017)
Table Global Dilated Cardiomyopathy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Dilated Cardiomyopathy Therapeutics Market Share by Regions in 2016
Figure United States Dilated Cardiomyopathy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Dilated Cardiomyopathy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Dilated Cardiomyopathy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Dilated Cardiomyopathy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Dilated Cardiomyopathy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Dilated Cardiomyopathy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Dilated Cardiomyopathy Therapeutics Market Share by Application in 2016
Figure Dilated Cardiomyopathy Therapeutics Market Size (Million USD) and Growth Rate in Applications 1 (2012-2017)
Figure Dilated Cardiomyopathy Therapeutics Market Size (Million USD) and Growth Rate in Applications 2 (2012-2017)
Figure Dilated Cardiomyopathy Therapeutics Market Size (Million USD) and Growth Rate in Applications 3 (2012-2017)
Table Dilated Cardiomyopathy Therapeutics Market Size (Million USD) by Players (2016 and 2017)
Figure Dilated Cardiomyopathy Therapeutics Market Size Share by Players in 2016
Figure Dilated Cardiomyopathy Therapeutics Market Size Share by Players in 2017
Table Array BioPharma Basic Information List
Table Dilated Cardiomyopathy Therapeutics Business Revenue (Million USD) of Array BioPharma (2012-2017)
Figure Array BioPharma Dilated Cardiomyopathy Therapeutics Business Revenue Market Share in 2016
Table AstraZeneca Basic Information List
Table Dilated Cardiomyopathy Therapeutics Business Revenue (Million USD) of AstraZeneca (2012-2017)
Figure AstraZeneca Dilated Cardiomyopathy Therapeutics Business Revenue Market Share in 2016
Table Celladon Corporation Basic Information List
Table Dilated Cardiomyopathy Therapeutics Business Revenue (Million USD) of Celladon Corporation (2012-2017)
Figure Celladon Corporation Dilated Cardiomyopathy Therapeutics Business Revenue Market Share in 2016
Table GlaxoSmithKline Basic Information List
Table Dilated Cardiomyopathy Therapeutics Business Revenue (Million USD) of GlaxoSmithKline (2012-2017)
Figure GlaxoSmithKline Dilated Cardiomyopathy Therapeutics Business Revenue Market Share in 2016
Table Janssen Pharmaceuticals Basic Information List
Table Dilated Cardiomyopathy Therapeutics Business Revenue (Million USD) of Janssen Pharmaceuticals (2012-2017)
Figure Janssen Pharmaceuticals Dilated Cardiomyopathy Therapeutics Business Revenue Market Share in 2016
Table Merck & Co Basic Information List
Table Dilated Cardiomyopathy Therapeutics Business Revenue (Million USD) of Merck & Co (2012-2017)
Figure Merck & Co Dilated Cardiomyopathy Therapeutics Business Revenue Market Share in 2016
Table Novartis International Basic Information List
Table Dilated Cardiomyopathy Therapeutics Business Revenue (Million USD) of Novartis International (2012-2017)
Figure Novartis International Dilated Cardiomyopathy Therapeutics Business Revenue Market Share in 2016
Table Pfizer Basic Information List
Table Dilated Cardiomyopathy Therapeutics Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Dilated Cardiomyopathy Therapeutics Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Dilated Cardiomyopathy Therapeutics Business Revenue (Million USD) of Sanofi (2012-2017)
Figure Sanofi Dilated Cardiomyopathy Therapeutics Business Revenue Market Share in 2016
Table Teva Pharmaceutical Industries Basic Information List
Table Dilated Cardiomyopathy Therapeutics Business Revenue (Million USD) of Teva Pharmaceutical Industries (2012-2017)
Figure Teva Pharmaceutical Industries Dilated Cardiomyopathy Therapeutics Business Revenue Market Share in 2016
Table Vericel Corporation Basic Information List
Table Dilated Cardiomyopathy Therapeutics Business Revenue (Million USD) of Vericel Corporation (2012-2017)
Figure Vericel Corporation Dilated Cardiomyopathy Therapeutics Business Revenue Market Share in 2016
Table PhaseBio Pharmaceuticals Basic Information List
Table Dilated Cardiomyopathy Therapeutics Business Revenue (Million USD) of PhaseBio Pharmaceuticals (2012-2017)
Figure PhaseBio Pharmaceuticals Dilated Cardiomyopathy Therapeutics Business Revenue Market Share in 2016
Table Johnson and Johnson Basic Information List
Table Dilated Cardiomyopathy Therapeutics Business Revenue (Million USD) of Johnson and Johnson (2012-2017)
Figure Johnson and Johnson Dilated Cardiomyopathy Therapeutics Business Revenue Market Share in 2016
Table Global Dilated Cardiomyopathy Therapeutics Market Size (Million USD) by Application (2012-2017)
Figure Global Dilated Cardiomyopathy Therapeutics Market Size (Million USD) by Application in 2012
Figure Global Dilated Cardiomyopathy Therapeutics Market Size (Million USD) by Application in 2013
Figure Global Dilated Cardiomyopathy Therapeutics Market Size (Million USD) by Application in 2014
Figure Global Dilated Cardiomyopathy Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Dilated Cardiomyopathy Therapeutics Market Size (Million USD) by Application in 2016
Figure Global Dilated Cardiomyopathy Therapeutics Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Dilated Cardiomyopathy Therapeutics
Figure United States Dilated Cardiomyopathy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Dilated Cardiomyopathy Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure United States Dilated Cardiomyopathy Therapeutics Market Size Share by Players in 2016
Figure United States Dilated Cardiomyopathy Therapeutics Market Size Share by Players in 2017
Figure EU Dilated Cardiomyopathy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Dilated Cardiomyopathy Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure EU Dilated Cardiomyopathy Therapeutics Market Size Share by Players in 2016
Figure EU Dilated Cardiomyopathy Therapeutics Market Size Share by Players in 2017
Figure Japan Dilated Cardiomyopathy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Dilated Cardiomyopathy Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Japan Dilated Cardiomyopathy Therapeutics Market Size Share by Players in 2016
Figure Japan Dilated Cardiomyopathy Therapeutics Market Size Share by Players in 2017
Figure China Dilated Cardiomyopathy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Dilated Cardiomyopathy Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure China Dilated Cardiomyopathy Therapeutics Market Size Share by Players in 2016
Figure China Dilated Cardiomyopathy Therapeutics Market Size Share by Players in 2017
Figure India Dilated Cardiomyopathy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Dilated Cardiomyopathy Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure India Dilated Cardiomyopathy Therapeutics Market Size Share by Players in 2016
Figure India Dilated Cardiomyopathy Therapeutics Market Size Share by Players in 2017
Figure Southeast Asia Dilated Cardiomyopathy Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Dilated Cardiomyopathy Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Dilated Cardiomyopathy Therapeutics Market Size Share by Players in 2016
Figure Southeast Asia Dilated Cardiomyopathy Therapeutics Market Size Share by Players in 2017
Figure Global Dilated Cardiomyopathy Therapeutics Market Size (Million USD) by Regions (2017-2022)
Table Global Dilated Cardiomyopathy Therapeutics Market Size (Million USD) by Regions (2017-2022)
Figure Global Dilated Cardiomyopathy Therapeutics Market Size Share by Regions in 2017
Figure Global Dilated Cardiomyopathy Therapeutics Market Size Share by Regions in 2022
Figure United States Dilated Cardiomyopathy Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Dilated Cardiomyopathy Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Dilated Cardiomyopathy Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Dilated Cardiomyopathy Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Dilated Cardiomyopathy Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Dilated Cardiomyopathy Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Dilated Cardiomyopathy Therapeutics Market Size (Million USD) by Application (2017-2022)
Figure Global Dilated Cardiomyopathy Therapeutics Market Size (Million USD) by Application in 2017
Figure Global Dilated Cardiomyopathy Therapeutics Market Size (Million USD) by Application in 2022